Fluidigm Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
16,526.00
52,830.00
53,315.00
75,985.00
60,535.00
59,013
Depreciation, Depletion & Amortization
2,551.00
13,861.00
16,115.00
17,938.00
18,609.00
16,572
Other Funds
4,957.00
24,195.00
10,738.00
14,197.00
8,624.00
16,856
Funds from Operations
9,018.00
14,774.00
26,462.00
43,850.00
33,302.00
25,585
Changes in Working Capital
7,427.00
7,849.00
8,234.00
4,752.00
9,204.00
2,478
Net Operating Cash Flow
1,591.00
22,623.00
34,696.00
39,098.00
24,098.00
28,063
Capital Expenditures
4,686.00
7,403.00
10,652.00
5,065.00
1,616.00
Sale of Fixed Assets & Businesses
3,117.00
-
-
-
-
Purchase/Sale of Investments
25,996.00
57,792.00
36,396.00
50,167.00
19,274.00
Net Investing Cash Flow
27,565.00
178,385.00
25,744.00
45,102.00
17,658.00
Issuance/Reduction of Debt, Net
-
195,213.00
-
-
-
Net Financing Cash Flow
5,806.00
200,326.00
5,303.00
76.00
28,997.00
Net Change in Cash
23,388.00
1,548.00
4,596.00
5,928.00
23,011.00
Free Cash Flow
5,037.00
30,026.00
38,678.00
44,163.00
25,664.00
Net Assets from Acquisitions
-
113,190.00
-
-
-
Change in Capital Stock
5,806.00
5,113.00
5,303.00
76.00
28,997.00
Exchange Rate Effect
38.00
866.00
947.00
152.00
454.00

About Fluidigm

View Profile
Address
7000 Shoreline Court
South San Francisco California 94080
United States
Employees -
Website http://www.fluidigm.com
Updated 07/08/2019
Fluidigm Corp. engages in the manufacture and marketing of innovative technologies and tools for life sciences research. It sells instruments and consumables, including integrated fluidic circuits; assays and reagents to academic institutions; clinical research laboratories, and biopharmaceutical; agricultural biotechnology; and companies and contract research organizations. The company was founded by Stephen R.